Here are five things to know:
1. Since Sept. 2, 2016, Mr. Vizirgianakis has been serving as Misonix’s interim CEO.
2. Mr. Vizirgianakis has served as a Misonix board member since May 2013.
3. His career saw him as Norwalk, Conn.-based United States Surgical Corp.’s sales director for sub-Saharan Africa. He also served Ascendis Medical’s managing director until July 2016.
4. He co-founded Surgical Innovations, located in Johannesburg, South Africa.
5. After investing $4 million in Misonix on Oct. 25, 2016, Mr. Vizirgianakis became the company’s largest shareholder.
More articles on devices:
Zimmer Biomet’s growth strategy in spine: MIS, cervical and becoming a ‘health solutions provider’
Predictive Technology Group highlights US patent allowance for treating patients with genetic spinal deformities, syndromes: 5 highlights
Global wearable medical devices market to hit $12.1B by 2021: 9 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
